Outcomes of dysplasia arising in Barrett's esophagus: a dynamic view
- PMID: 12946790
- DOI: 10.1016/S1072-7515(03)00417-4
Outcomes of dysplasia arising in Barrett's esophagus: a dynamic view
Abstract
Background: The management of dysplasia arising in Barrett's esophagus is controversial.
Study design: Twenty patients (group 1, prompt attitude) underwent operation as soon as high-grade dysplasia (HGD) was discovered (n = 8) or just after either the presence of HGD was confirmed (n = 9) or invasive carcinoma (IC) was found (n = 3) in a second set of biopsy samples taken soon after HGD had been discovered. In contrast, esophagectomy in 13 patients (group 2, expectant attitude) was performed only because HGD persisted (n = 4) or turned into IC (n = 4) at endoscopic followup (7 to 23 months) (subgroup 2a, n = 8) or because HGD (n = 2) or low-grade dysplasia (LGD) (n = 3) was disregarded until dysphagia and IC developed (12 to 70 months) (subgroup 2b, n = 5). Skeletonizing en-bloc esophagectomy was performed in 29 patients and four patients (three with HGD and one with mucosal IC in the resected specimen) underwent vagus-sparing esophagectomy.
Results: Invasive carcinoma was found in 11 of 24 patients (45.8%) supposed to have only HGD (in repeat biopsies in 3 patients from group 1 and in the resected specimen in eight of 21 patients (38%) operated on for HGD. Metastatic lymph nodes were found in the resected specimen of seven patients (group 1: one of 20 or 5%, versus subgroup 2a: two of eight or 25%, versus subgroup 2b: four of five or 80%; p = 0.001). Unlike none of the 26 patients (0%) with an intramural process, five of the seven patients (71.4%) with an extramural process (one had had disregarded LGD) developed neoplastic recurrence at followup (p < 0.0001). Cancer-related survival in the long term was 100% in group 1 versus 52.5% in group 2 (p = 0.0094).
Conclusions: Invasive carcinoma is present in almost one half of patients with HGD within a Barrett's area. Promptness in the decision regarding an esophageal resection as soon as HGD is found is much safer than expectant observation. Not enrolling a patient with LGD in an endoscopic surveillance program can lead to the development of extramural IC with poor outcomes.
Similar articles
-
Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.Am J Gastroenterol. 2009 Nov;104(11):2684-92. doi: 10.1038/ajg.2009.465. Epub 2009 Aug 18. Am J Gastroenterol. 2009. PMID: 19690526
-
Oesophagectomy remains the gold standard for treatment of high-grade dysplasia in Barrett's oesophagus.Eur J Cardiothorac Surg. 2005 Nov;28(5):763-6. doi: 10.1016/j.ejcts.2005.08.018. Epub 2005 Sep 26. Eur J Cardiothorac Surg. 2005. PMID: 16188449
-
Surgical treatment of esophageal high-grade dysplasia.Ann Thorac Surg. 2005 Apr;79(4):1110-5; discussion 1110-5. doi: 10.1016/j.athoracsur.2004.09.006. Ann Thorac Surg. 2005. PMID: 15797034
-
Controversies in Barrett's esophagus: management of high grade dysplasia.Semin Gastrointest Dis. 2001 Jan;12(1):26-32. Semin Gastrointest Dis. 2001. PMID: 11215852 Review.
-
Barrett's esophagus: management of high-grade dysplasia and cancer.J Surg Res. 2004 Mar;117(1):44-51. doi: 10.1016/j.jss.2003.10.021. J Surg Res. 2004. PMID: 15013713 Review.
Cited by
-
The risk of lymph-node metastases in patients with high-grade dysplasia or intramucosal carcinoma in Barrett's esophagus: a systematic review.Am J Gastroenterol. 2012 Jun;107(6):850-62; quiz 863. doi: 10.1038/ajg.2012.78. Am J Gastroenterol. 2012. PMID: 22488081 Free PMC article.
-
Treatment for Barrett's oesophagus.Cochrane Database Syst Rev. 2010 Jan 20;2010(1):CD004060. doi: 10.1002/14651858.CD004060.pub2. Cochrane Database Syst Rev. 2010. Retraction in: Cochrane Database Syst Rev. 2021 Mar 4;3:CD004060. doi: 10.1002/14651858.CD004060.pub3. PMID: 20091557 Free PMC article. Retracted.
-
Minimally invasive esophagectomy for dysplastic Barrett's esophagus.World J Surg. 2015 Mar;39(3):608-14. doi: 10.1007/s00268-014-2746-1. World J Surg. 2015. PMID: 25145822 Review.
-
Endoscopic treatments for Barrett's esophagus: a systematic review of safety and effectiveness compared to esophagectomy.BMC Gastroenterol. 2010 Sep 27;10:111. doi: 10.1186/1471-230X-10-111. BMC Gastroenterol. 2010. PMID: 20875123 Free PMC article.
-
Preemptive surgery for premalignant foregut lesions.J Gastrointest Surg. 2009 Oct;13(10):1874-87. doi: 10.1007/s11605-009-0935-2. Epub 2009 Jun 10. J Gastrointest Surg. 2009. PMID: 19513795
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials